Frequently Asked Questions

The questions we hear most — about safety, suitability, what treatment involves, and how to begin. Answered directly by our clinical team.

Most people arrive here with the same questions.

About safety. About legality. About whether this is right for them. About what actually happens during a session.

These are good questions. They deserve direct answers.

If something is not covered here, we are happy to answer it directly.


About the Process

How do I know if I am a suitable candidate?

You do not need to know before you contact us. That is what the initial consultation is for.

During a confidential clinical discussion, we review your history, your current condition, and your goals. From there, we determine whether Psychedelic-Assisted Psychotherapy is appropriate for your situation — and if so, how a programme should be structured.

If you are not a suitable candidate, we will tell you clearly. And where possible, we will point you toward something that may serve you better.

What happens in the first consultation?

It is a conversation, not an assessment form.

We listen to your story — what you have been through, what you have already tried, and what you are looking for. You can ask us anything: about the science, the process, the risks, the realistic range of outcomes. There is no obligation attached. No assumption that treatment will follow.

How long does a full programme take?

Every programme is designed around the person, not a standard template.

Most programmes involve between four and eight supervised sessions over two to four weeks. The full arc — including preparation and integration — typically spans four to six weeks from first session to final integration appointment.

Some conditions warrant a different structure. Your lead physician determines what is appropriate for your clinical picture.

Where the evidence supports it, maintenance sessions can be scheduled beyond the initial programme. Not as a default — but as a clinical option for those whose progress warrants continued support.

A programme at Enthea does not end on a fixed date. It ends when we are satisfied with where you are.

Do I need a prior diagnosis?

No.

Some people come to us with a formal psychiatric diagnosis. Others come with a clear sense that something is not working — without a label attached to it.

Both are valid. Our assessment process works from your experience and your history, not from whether a previous clinician has given it a name.


Can I continue my current medication during treatment?

This is assessed individually and carefully.

Certain medications are contraindicated with Psychedelic-Assisted Psychotherapy. Others are not. Your full medication history is reviewed during the medical assessment, and any necessary adjustments are discussed with your prescribing physician before treatment begins.

We do not ask anyone to discontinue medication without medical justification and proper clinical oversight.


About Safety

Is this safe?

Psychedelic-Assisted Psychotherapy, administered in a supervised clinical setting by qualified physicians, has a well-documented safety profile in the research literature.

It is not without risk. No medical intervention is.

Physiological monitoring is continuous throughout every session. A multidisciplinary team — psychiatrist, psychologist, and specialist nurse — is present at all times. You are not left alone at any point.

The risks specific to your situation are discussed in full during your medical assessment. If those risks are not manageable within our clinical framework, we will not proceed.

Are there people for whom this is not appropriate?

Yes.

There are absolute and relative contraindications — medical and psychiatric conditions that make this approach unsuitable or require particular caution. These include certain cardiovascular conditions, a personal or family history of psychosis, and specific medication interactions.

This is precisely why the assessment exists. We screen carefully. We do not proceed if contraindications are present.

What if the experience is difficult?

Challenging experiences during sessions can occur. They are not, in themselves, a sign that something has gone wrong.

Your physician will have prepared you for the range of what may arise before your first session. During the session, your clinical team is present throughout — not observing from a distance, but actively supporting.

Difficult material that surfaces during a session is often clinically significant. How it is held in the moment, and how it is processed in integration, determines what it becomes.


About the Science

Is there real clinical evidence for this?

Yes. A substantial and growing body of it.

Randomised controlled trials published in The New England Journal of Medicine, Nature Medicine, and JAMA Psychiatry — conducted at Imperial College London, Johns Hopkins University, and NYU Langone Health — have documented clinically significant outcomes across depression, PTSD, anxiety, and addiction.

Our science page summarises the most relevant research in full.

Is this experimental?

The approach is evidence-based, not experimental in the clinical sense.

The research behind Psychedelic-Assisted Psychotherapy includes Phase 2 and Phase 3 randomised controlled trials — the same standard applied to conventional pharmacological treatments before approval.

What is true is that this field is still developing. Long-term data beyond 12 months is limited for some conditions. We are transparent about what the evidence shows — and about where gaps remain.

How does it compare to conventional antidepressants?

A study published in The New England Journal of Medicine (2021) from Imperial College London compared this approach directly with a leading conventional antidepressant. Both produced comparable reductions in depressive symptoms. The Psychedelic-Assisted approach showed faster onset and higher rates of sustained response at the six-week mark.

It is not a replacement for conventional treatment in all cases. It is a clinically distinct option — particularly for people for whom conventional approaches have not produced adequate response.


About Enthea

Where are you located?

Marina Botafoch, Ibiza. Our clinic is a private, purpose-designed environment built specifically for this work.

Do you only treat people who come to Ibiza?

At present, all treatment takes place at our clinic in Ibiza. The supervised sessions require an in-person clinical setting — this cannot be replicated remotely.

Initial consultations can be conducted by video. We work with people travelling specifically for treatment as well as those based in Spain or resident on the island.

Is my information confidential?

Completely.

All clinical information is held in accordance with Spanish data protection law (LOPDGDD) and the General Data Protection Regulation (GDPR). Nothing is shared without your explicit consent.

Our privacy policy sets out exactly how your data is handled.

How do I take the next step?

A confidential consultation — no obligation, no pressure.

You tell us where you are. We tell you honestly whether we can help.

If this resonates, we can talk.



Enthea Institute is a medically supervised
psychedelic therapy clinic based in Ibiza, Spain.
All treatment is administered by qualified
physicians in full compliance with Spanish
healthcare regulations. This page is
for informational purposes only and does
not constitute medical advice.